Synthility helps small-molecule drug discovery teams accelerate chemistry program execution by eliminating administrative bottlenecks. Our chemistry-native platform aims to orchestrate synthesis execution at a program level, replacing fragmented workflows across PowerPoint, spreadsheets, email and CRO systems, enabling teams to execute more chemistry with the same resources. Our first platform product, PatentFast, reduces patent-ready experimental preparation from weeks to hours. We intend to sell all products as subscription SaaS to biotech and pharma teams. Synthility was founded by a PhD chemist with deep drug discovery and biotech experience and a software engineer responsible for the technology, combining domain expertise with the capability to build the solution ourselves.

